2015-02450. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

The meeting announced below concerns “Comprehensive High-Impact HIV Prevention Projects for Community-Based Organizations”, Funding Opportunity Announcement (FOA) PS15-1502, initial review.

In accordance with Section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date: 9:00 a.m.-4:00 p.m., EST, Panels 1-5; March 3, 2015 (Closed).

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Comprehensive High-Impact HIV Prevention Projects for Community-Based Organizations” FOA PS15-1502. The panel is reconvening to review 44 additional applications that have been deemed eligible for FOA PS15-1502.

Contact Person for More Information: Elizabeth Wolfe, Public Health Advisor, CDC, 1600 Clifton Road, NE., Mailstop E07, Atlanta, Georgia 30333, Telephone: [phone].

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.